Open AccessAbstract 2041: Suppression of mutant p53-induced EMT by statins have double-edged effects on the patients with lung adenocarcinoma according to p53 mutation status
Author(s) -
Shigeto Nishikawa,
Toshi Menju,
Terumasa Sowa,
Koji Takahashi,
Ryo Miyata,
Hiroyuki Ishikawa,
Daisuke Nakajima,
Masatsugu Hamaji,
Hideki Motoyama,
Akihiro Aoyama,
Toshihiko Satō,
Fengshi Chen-Yoshikawa,
Makoto Sonobe,
Hiroshi Date
Publication year - 2018
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-2041
Subject(s) - vimentin , adenocarcinoma , immunostaining , epithelial–mesenchymal transition , biology , cancer research , lung cancer , mutant , transfection , metastasis , cancer , matrigel , oncology , medicine , pathology , immunohistochemistry , immunology , cell culture , gene , genetics , angiogenesis